“We imagine that instead of using antibiotics, you might produce for example eye drops with the mucin that normally removes the bacteria in the treatment of eye infections,” says Associate Professor Yoshiki Narimatsu
The body is filled with mucus that keeps track of the bacteria. Now, researchers from the University of Copenhagen present the first method for producing artificial mucus. They hope that the artificial mucus, which consists of sugary molecules, may help to develop completely new, medical treatments.
Many people instinctively associate mucus with something disgusting, but in fact, it has incredibly many valuable functions for our health. It keeps track of our important intestinal flora and feeds the bacteria. It covers all internal surfaces of our body, and, as a barrier to the outside world, it helps us protect ourselves from infectious diseases.
This is because mucus acts as a filter that keeps the bacteria in or out, and the bacteria feed on the sugars in the mucus between meals. So, if we can produce the mucus that is already present in the body with the right sugars, it might be used in brand new medical treatments.
Now, researchers from the DNRF Centre of Excellence, Copenhagen Center for Glycomics, have discovered how to artificially produce the healthy mucus.
‘We have developed a method for producing the important information found in human mucus, also called mucins, with their important sugars. Now, we show that it is possible to artificially produce it in the same way as we produce other therapeutic biologics today, such as antibodies and other biological medicine’, says Professor Henrik Clausen, lead author of the study and Director of the Copenhagen Center for Glycomics.
The mucus, or mucins, consist mostly of sugars. In the study, the researchers show that it is actually special patterns of sugars on the mucins that the bacteria recognise.
‘It is the body’s way of selecting the good bacteria and deselecting those that cause diseases. And it is precisely the sugars in the mucus that we are now able to design as needed’, says first author of the study, Ph.D. student Rebecca Nason.
A giant fishing net of mucus
The researchers are particularly interested in the mucus in the gastrointestinal tract. Like a giant fishing net, the mucus keeps track of all the bacteria, our microbiome, down there. So, if one could imitate the ability of bacteria to attach to the intestinal mucus, one could design oral medications that stick to the mucus, making them more effective.
‘We have found a small molecule from bacteria – which we call X409 – that binds to the intestine, and that is precisely one of the many possibilities we are now working on’, says Rebecca Nason.
It can be difficult to get medicine to be effective when it has to be ingested and absorbed into our intestinal system. So, when you design your drug as a pill that the patient swallows, it is not certain that it will be fully efficient.
There are many obstacles on the way down through the digestive system, and the medication needs time in the gastrointestinal tract to be dissolved and distributed in the body’, explains Rebecca Nason.
Mucus may become a new treatment
We swallow more than a litre of mucus in the form of saliva per day and more from the stomach, which together with the ever-changing fishing net of mucus in the intestine feed our intestinal microbiome. The microbiome of the intestine is absolutely crucial to our health and of great importance in relation to many diseases.
‘An incredible number of diseases have a connection to the intestinal flora, but we still know very little about how we can control the intestinal flora in the treatment of diseases. This is where synthetic mucins could open up new treatment options’, says Associate Professor Yoshiki Narimatsu, another of the lead authors of the study.
’Ultimately, one can imagine using mucins as a pre-biotic material, that is, as molecules that help the good bacteria in the body’, says Yoshiki Narimatsu.
With artificial mucus, it will also be possible to alleviate infections in the body. Mucus in saliva flushes out bacteria and cleans the oral cavity, and mucus constantly runs down over our eyes and keeps them clean.
‘We imagine that instead of using antibiotics, you might produce for example eye drops with the mucin that normally removes the bacteria in the treatment of eye infections. In concrete terms, this means that mucin can dissolve the so-called biofilm of bacteria, which is often pathogenic’, says Yoshiki Narimatsu.
Biofilm is a film of bacteria on the surface of a material and is, among other things, what you can feel on your teeth if it has been a long time since you last brushed them.
Mucins also affect the flu virus
It is not only bacteria that recognise mucins.
‘We also show that mucins are very important for the way in which the common flu virus infects our mucous membranes in competition with mucins which inhibit the infection and flush out the virus’, says Yoshiki Narimatsu.
Unlike the covid-19 virus, influenza virus binds to a sugar, which is found on all mucins, and a sugar has already been developed for treatment of the flu.
‘We hope mucins may work even better’, says Yoshiki Narimatsu.
Original Article: Mucus and mucins may become the medicine of the future
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Home screening test for oral or throat cancer has 90 per cent accuracy
To identify oral and throat cancer, lesions have to be big enough for doctors to see. A saliva test could enable much earlier diagnosis ...
- Xerostomia (Dry Mouth Disease) Therapeutics Market 2022, Worth USD 668.4 Mn by 2028 at CAGR of 2.3% – Report Spread across 101 Pages
Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, ...
- Lord's Mark Industries collaborates with Sensing Self to launch 99 per cent accuracy rate COVID-19 Saliva-based Rapid Antigen Test Kit in India
Mumbai Maharashtra [India] August 2 ANINewsVoir LordsMed the pharma division of Lord Mark Industries Pvt Ltd has entered into an Exclusive partnership with Singapore-based diagnostics kit manufacturer ...
- LordsMed, Sensing Self To Launch Saliva-based Covid Test Kit In India
As a part of the agreement with Sensing Self, Lord’s Mark Industries will collaborate with various government agencies and authorities to offer the Covid-19 saliva-based rapid antigen kits to support ...
- Cilia Are Minuscule Wonders, and Scientists Are Finally Figuring Out How to Mimic Them
This chip is covered with hundreds of artificial cilia ... transport eggs from the ovary to the uterus, and drain mucus from the middle ear to the nasal cavity. These tiny, extracellular ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- The role of the biochemical features of the SARS-CoV-2 spike protein in human transmission
Researchers evaluated all biochemical changes in SARS-CoV-2 spike protein to explore their evolutionary significance.
- COVID in California: Reinfections account for 1 in 7 coronavirus cases in state
California’s COVID-19 case rates seem to be stalled again, at a high level, after a period of fluctuating numbers and a few days that looked like the situation might be improving. But tourism, San ...
- Explained: How lung proteins tackle COVID-19 infections
In the study, published in the journal Nature Genetics, researchers used CRISPR technology to test the impact of every human gene on SARS-CoV-2 infections in human lung cells. Their findings revealed ...
- How human lung proteins tackle Covid-19 infections
In a study, researchers used CRISPR technology to test the impact of every human gene on SARS-CoV-2 infections in human lung cells.
- Study finds lung cells regulate SARS-CoV-2 infection
Researchers at UC Berkeley’s Hsu Lab identified human lung proteins that can either promote or restrict infection from SARS-CoV-2.